StockData
Oculis Holding AG logo

Oculis Holding AG (OCS) stock

OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.39−0.12 (-1.60%)

Close on Nov 18, 2026Market cap $444.06MP/E –Yield –

Oculis net income

Net income is the profit left for shareholders after every expense, interest and tax.

No net income figures for Oculis

Oculis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Oculis figures

See a number that looks wrong?